This is a working overview of cold chain, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-12. Anything still debated is marked as such rather than presented as settled.
Handling guidance for research quantities calls for single-use aliquots, an inert atmosphere where practical, and avoidance of repeated freeze-thaw cycles that accelerate aggregation. Certificates of analysis typically report purity by peak area, water content, counter-ion identity, and residual solvent levels. In the scientific literature the compound is usually described by its full amino acid sequence, its registry number, or its structural class rather than by any proprietary label. Reporting standards vary between journals, and reviewers increasingly request raw chromatograms alongside tabulated purity figures. Whether current purity thresholds are adequate for every experimental context is debated.
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the dominant approach for peptide purity assessment, usually paired with mass spectrometry to confirm molecular mass and sequence. Peptide mapping by enzymatic digestion and tandem mass spectrometry locates modifications such as deamidation and oxidation. Quantitation in plasma matrices can be performed by LC-MS/MS after solid-phase extraction. Method validation follows general guidance on accuracy, precision, linearity, and limits of detection. Comparability of results between laboratories, when no shared reference standard is available, remains an open question.
Stability studies focus on deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation into higher-order species. The fatty acid side chain adds susceptibility to oxidative change and can promote self-association at high concentration. Lyophilised material is comparatively robust when kept cold and dry, while aqueous solutions require refrigeration and protection from light. Forced degradation experiments under heat, acid, base, and peroxide conditions establish the specificity of each analytical method. Which degradation route dominates under real storage conditions depends on the formulation and stays formulation-specific.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
| Property | Value | Notes |
|---|---|---|
| Typical purity assay | reversed-phase HPLC, 220 nm | Amide-bond detection for the peptide backbone |
| Identity confirmation | electrospray mass spectrometry | Peptide mapping used for sequence coverage |
| Related substances | deamidated and oxidised forms | Truncated sequences also monitored |
| Powder storage | -20 degrees Celsius | Keep sealed, dry, and protected from light |
| Solution storage | 2 to 8 degrees Celsius | Avoid repeated freeze-thaw cycling |
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
Quantification and purity assessment rely on separation methods coupled to optical or mass detection. Reversed-phase high-performance liquid chromatography resolves the intact peptide from related impurities and is the standard assay technique. Size-exclusion chromatography measures aggregates, while ion-exchange chromatography separates charge variants produced by deamidation. Mass spectrometry confirms identity and detects mass shifts of a few daltons. In biological matrices, liquid chromatography with tandem mass spectrometry is often used because immunoassays can cross-react with endogenous GLP-1 or with circulating fragments.
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L-cells after food intake. It contains 31 amino acids and differs from native GLP-1 through modifications that slow enzymatic breakdown. The peptide was developed to extend the short circulating half-life of endogenous GLP-1, which is measured in minutes. Researchers introduced the compound in the early 2010s. Two backbone changes and a fatty acid side chain define its structure, distinguishing it from earlier GLP-1 receptor agonists.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities by hydrophobicity. Mass spectrometry confirms molecular weight and detects truncation or modification products. Peptide mapping after enzymatic digestion verifies the amino acid sequence. Quantitation is often performed by LC-MS/MS or by immunoassay, and the two approaches can give different values because they measure different things. Method validation parameters such as accuracy, precision, and limit of quantitation are reported alongside results.
Certificate of analysis documents from suppliers typically report purity by chromatographic area, water content, and counter-ion identity. Independent verification is advisable because reported values can be generated under differing conditions. Impurity profiles matter for research use, where aggregates, deamidation products, and residual solvents may influence experimental results. Container, lot, and chain-of-custody records support traceability. Analytical results are method-dependent, so comparisons between laboratories require the same procedure and reference standards.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Bussolari of the MIT Lincoln Laboratory; the aerodynamicist was Mark Drela, with his XFOIL; in 1986, the team moves to Hanscom Field; the pilot Lois McCallin; after three to four hours of heavy exercise, the body's glucose is depleted; the first test aircraft had no ailerons, to save weight, resulting in a crash; a Hellenic Air Force C-130 arrives at Heraklion International Airport on 26 March 1988; three pilots train on Crete, eating around 7000 calories per day; the flight occurs on Saturday 23 April 1988, flying at around 18 knots; a gust of wind snapped the tail boom and wing on the beach. A US production, narrated by Andrew Sachs, produced by Mark Davis, made by WGBH. Shown on Nova on 22 November 1988 14 October Junk Mail, about direct marketing, increased by the affordability of computers, with Erik Larson.
== De-adenylylators == De-AMPylation is the reverse reaction in which the AMP molecule is detached from the amino acid side of a chain protein. There are three known mechanisms for this reaction. The bacterial GS-ATase (GlnE) encodes a bipartite protein with separate N-terminal AMPylation and C-terminal de-AMPylation domains whose activity is regulated by PII and associated posttranslational modifications. De-AMPylation of its substrate AMPylated glutamine synthetase proceeds by a phosphorolytic reaction between the adenyl-tyrosine of GS and orthophosphate, leading to the formation of ADP and unmodified glutamine synthetase. SidD, a protein introduced in the host cell by the pathogenic bacteria Legionella pneumophila, de-AMPylates Rab1 a host protein AMPylated by a different Legionella pneumophila enzyme, the AMPylase SidM. Whilst the benefit to the pathogen of introducing these two antagonistic effectors in the host remains unclear, the biochemical reaction carried out by SidD involves the use of a phosphatase-like domain to catalyse the hydrolytic removal of the AMP from tyrosine 77 of the host's Rab1. In animal cells the removal of AMP from threonine 518 of BiP/Grp78 is catalysed by the same enzyme, FICD, that AMPylates BiP. Unlike the bacterial GS-ATase, FICD carries out both reactions with same catalytic domain.
The first investigation conducted in China was by the Wuhan Municipal Health Commission, responding to hospitals reporting cases of pneumonia of unknown etiology, resulting in the closure of the Huanan Seafood Wholesale Market on 1 January 2020 for sanitation and disinfection. The Chinese Center for Disease Control and Prevention (CCDC) entered the market the same day and took samples; as the animals had been removed before public-health authorities came in, no animals were sampled, although that would have been more conclusive. In April 2020, China imposed restrictions on publishing academic research on the novel coronavirus. Investigations into the origin of the virus would receive extra scrutiny and must be approved by Central Government officials. The restrictions do not ban research or publication, including with non-Chinese researchers; Ian Lipkin, a US scientist, has been working with a team of Chinese researchers under the auspices of the Chinese Center for Disease Control and Prevention, a Chinese government agency, to investigate the origin of the virus. Lipkin has long-standing relationships with Chinese officials, including premier Li Keqiang, because of his contributions to rapid testing for SARS in 2003. The Huanan live-animal market was suspected of being the source of the virus, as there was a major, early cluster of cases there. On 31 January 2021, a team of scientists led by the World Health Organization visited the market to investigate the origins of COVID-19.
In 1989, he played the role of Glen in two episodes of the television show The New Lassie. At the beginning of his career, DiCaprio had difficulty finding an agent. When he finally found one, the agent suggested that he change his name to Lenny Williams to appeal to American audiences, which he refused to do. DiCaprio remained jobless for a year and a half, even despite 100 auditions. Following this frustrating lack of success, DiCaprio was about to give up acting but his father convinced him to persevere, and he continued to audition. After a talent agent (who knew a friend of his mother's) recommended him to casting directors, DiCaprio secured roles in about 20 commercials. By the early 1990s, DiCaprio began acting regularly on television, beginning with a role in the pilot of The Outsiders (1990) and one episode of the soap opera Santa Barbara (1990), in which he played an alcoholic teenager. Following this, DiCaprio was cast in Parenthood, a series based on the 1989 comedy film. To prepare for the role of Garry Buckman, a troubled teen, he analyzed Joaquin Phoenix's performance in the original film. His work that year earned him two nominations at the 12th Youth in Film Awards—Best Young Actor in a Daytime Series for Santa Barbara and Best Young Actor Starring in a New Television Series for Parenthood. Around this time, he was a contestant on the children's game show Fun House; on the show he performed several stunts, including catching the fish inside a small pool using only his teeth.
=== Major versus minor === Major cross-match: Here the Recipient serum is tested against donor packed cells to determine if the recipient has preformed antibodies against any antigens on the donor's cells. This is the required cross-match prior to release of a unit of packed cell from blood bank. Minor cross-match: Here the Recipient red cells are tested against donor serum to detect donor antibodies directed against a patient's antigens. This is no longer required. It is assumed that the small amount of donor serum and antibodies left in a unit of packed cells will be diluted in a recipient.
Sources: en.wikipedia.org
=== Chemical symbol === Deuterium is often represented by the chemical symbol D. Since it is an isotope of hydrogen with mass number 2, it is also represented by 2H. IUPAC allows both D and 2H, though 2H is preferred. A distinct chemical symbol is used for convenience because of the isotope's common use in various scientific processes. Also, its large mass difference with protium (1H) confers non-negligible chemical differences with 1H compounds. Deuterium has a mass of 2.014102 Da, about twice the mean hydrogen atomic weight of 1.007947 Da, or twice protium's mass of 1.007825 Da. The isotope weight ratios within other elements are largely insignificant in this regard.
== External links == WHO: Good Distribution Practices (GDP) for Pharmaceutical Products Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03) Counterfeit Drugs (FDA) Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs (FDA) GDP Guidelines of 7 March 2013 (Eudralex) Guidelines on Good Distribution Practice (NPCB/Malaysia) GDP Guidelines of 7 March 2013 (Eudralex) How to become pharmaceutical distributor
In 2017, around 70,200 Americans died from drug overdose. 28,466 deaths were associated with synthetic opioids such as fentanyl and fentanyl analogs, 15,482 were associated with heroin use, 17,029 with prescription opioids (including methadone), 13,942 with cocaine use, and 10,333 with psychostimulants (including methamphetamine). In 2021, there was an increase in overdose deaths; more than 106,000 drug-related overdoses occurred, including deaths caused by both illegal and prescribed opioids. Of this, 70,601 deaths were caused by synthetic opioids primarily fentanyl. Additionally, 32,537 overdose deaths involved stimulants like cocaine or psychostimulants with abuse potential (primarily methamphetamine). Between 2017 and 2019, rappers Lil Peep, Mac Miller, and Juice Wrld died of drug overdoses related to opioids. William D. Bodner of the Drug Enforcement Administration's Los Angeles field division and special agent in charge of the investigation into Miller's death said in a statement, "The tragic death of Mac Miller is a high-profile example of the tragedy that is occurring on the streets of America every day." In 2023, the Biden administration announced a crackdown on Mexican drug cartels smuggling fentanyl into the United States. The Biden administration also targeted Chinese companies importing chemicals used to make fentanyl. Rahul Gupta led White House efforts to combat the opioid epidemic.
Mild, Unconjugated Hyperbilirubinemia: Total serum bilirubin levels are mildly elevated, typically remaining below 6 mg/dL (102 μmol/L), with a predominance of the unconjugated (indirect) fraction. Normal Liver Function Tests: Liver enzymes, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are within normal ranges, indicating no underlying liver disease. Absence of Hemolysis: No evidence of increased red blood cell breakdown, as indicated by normal hemoglobin levels and reticulocyte counts. Intermittent Nature of Symptoms: Episodes of jaundice that may be triggered by factors such as fasting, illness, stress, or exertion, with no other associated symptoms. The level of total bilirubin is often further increased if the blood sample is taken after fasting for two days, and a fast can, therefore, be useful diagnostically. A further conceptual step that is rarely necessary or appropriate is to give a low dose of phenobarbital: the bilirubin will decrease substantially. Exclusion of Other Liver Disorders: No clinical or laboratory evidence of other liver diseases; imaging studies and serologic tests for hepatitis are negative. Genetic Testing: Identification of mutations in the UGT1A1 gene can confirm the diagnosis of Gilbert syndrome. While not routinely required, genetic testing may be considered in cases where the diagnosis is uncertain or to provide reassurance to patients.
Sources: en.wikipedia.org
== Veterinary use == Naltrexone is used in wild and zoo animals to reverse the effects of carfentanil and etorphine. Naltrexone has a longer duration of action than naloxone in most species, although not the dog, making it more desirable than naloxone which requires more frequent administration. Although typically used for high strength opioids like carfentanil and etorphine naltrexone can be used for other opioids and is suitable for use of reversing strong opioid doses in the cat. A quaternary ammonium compound, methylnaltrexone is still being investigated for use in veterinary medicine. Naltrexone antagonises the μ-, κ-, and δ-, but methylnaltrexone does not bind to the δ-opioid receptor and binds to the μ-opioid receptor at greater potency than the κ-opioid receptor and it does not cross the blood-brain barrier, which allows methylnaltrexone to treat peripheral effects of opioids such as gastrointestinal ileus whilst maintaining analgesia. However, methylnaltrexone may not treat the side effects of buprenorphine.
Cmax is the maximum (or peak) serum concentration that a drug achieves in a specified compartment or test area of the body after the drug has been administered and before the administration of a second dose. It is a standard measurement in pharmacokinetics.
9 May A record annual increase in atmospheric CO2 is reported from the Mauna Loa Observatory in Hawaii, with a jump of 4.7 parts per million (ppm) compared to a year earlier. A cubic millimetre of the human brain is mapped at nanoscale resolution by a team at Google. This contains roughly 57,000 cells and 150 million synapses, incorporating 1.4 petabytes of data. A study in Physical Review Letters concludes that the black hole in VFTS 243 likely formed instantaneously, with energy mainly expelled via neutrinos. This means it would have skipped the supernova stage entirely. An analysis of ocean protection for the global conservation target to protect at least 30% of the ocean by 2030 (30 by 30), finds around a quarter of marine protected area (MPA) coverage is not implemented, and one-third is incompatible with the conservation of nature due to the occurrence of highly destructive activities. According to the study, indicators of MPA quality, not only coverage, are needed. On 11 June, a study finds MPAs' effectiveness is not determined by any specific governance approaches or incentives, but the combination of many different integrated incentives. 10 May – A series of solar storms and intense solar flares impact the Earth, creating aurorae at more southerly and northerly latitudes than usual. 13 May – OpenAI reveals GPT-4o, its latest AI model, featuring improved multimodal capabilities in real time. 15 May Astronomers report an overview of preliminary analytical studies on returned samples of asteroid 101955 Bennu by the OSIRIS-REx mission.
== Breeding purposes == It will hybridize with common domestic tomatoes. There are annual, biennial, and perennial varieties. Solanum pimpinellifolium is important in tomato breeding. Its relatedness to tomatoes and ability to freely cross with them has allowed it to be used for the introduction of disease resistance traits in tomato varieties, as well as in the study of the genetic control of tomato traits such as fruit shape and size. It has higher amounts of lycopene, vitamin C, and phenolic acids, as well as a higher antioxidant capacity than Solanum lycopersicum. Its 900 Mb genome differs from the tomato at 0.6% of base pairs; in comparison, they both differ from the potato (from which they diverged 7.3 million years ago) at 8% of bases. In addition to its utilization in common tomato breeding, S. pimpinellifolium has also been the target of attempted de novo domestication, with the intent to create a separate domesticated species. This includes the use of CRISPR gene editing to replace 6 domestication-related loci, resulting in plants with altered architecture, and larger, more numerous fruits. Considered the ancestor of domesticated tomatoes, it is valued for supplementing the limited gene pool of the domestic tomato. Due to agricultural development, the wild currant tomato is becoming less prevalent in the native range of northern Peru and southern Ecuador.
The history of the U.S. legislation on AAS goes back to the late 1980s, when the U.S. Congress considered placing AAS under the Controlled Substances Act following the controversy over Ben Johnson's victory at the 1988 Summer Olympics in Seoul. AAS were added to Schedule III of the Controlled Substances Act in the Anabolic Steroids Control Act of 1990. The same act also introduced more stringent controls with higher criminal penalties for offenses involving the illegal distribution of AAS and human growth hormone. By the early 1990s, after AAS were scheduled in the U.S., several pharmaceutical companies stopped manufacturing or marketing the products in the U.S., including Ciba, Searle, Syntex, and others. In the Controlled Substances Act, AAS are defined to be any drug or hormonal substance chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promote muscle growth. The act was amended by the Anabolic Steroid Control Act of 2004, which added prohormones to the list of controlled substances, with effect from 20 January 2005. Even though they can still be prescribed by a medical doctor in the U.S., the use of anabolic steroids for injury recovery purposes has been a taboo subject, even amongst the majority of sports medicine doctors and endocrinologists.
Sources: en.wikipedia.org
Purity is commonly expressed as the percentage of the main peak relative to all integrated peaks in a reversed-phase chromatogram. Related substances and counter-ions are reported separately. Values obtained with different detectors are not always directly comparable.
Aggregation is driven by hydrophobic contacts, especially those involving the fatty acid side chain, and is accelerated by heat, agitation, and repeated freezing and thawing. Low pH and suitable excipients can reduce the rate. The tendency differs between formulations.
Dry powder has low molecular mobility and tolerates colder storage for longer periods. Water enables hydrolysis and conformational change, so dissolved material is kept refrigerated and used within a shorter window.
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.